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Correlates of genetic attributions among parents 
of children in the USA with developmental 
disabilities
Bridget Kiely
Sujit Vettam
Andrew Adesman
Division of Developmental and 
Behavioral Pediatrics, Department 
of Pediatrics, Steven and Alexandra 
Cohen Children’s Medical Center of 
New York, New Hyde Park, NY, USA
Introduction: As technologies for identifying causal genetic variants in children with autism 
spectrum disorders (ASD) and other developmental conditions continue to advance, there is a 
need to understand the factors that influence parental beliefs about the causes of their child’s 
disabilities. This study assessed the correlates of etiologic attributions among US parents of 
children with ASD, intellectual disability (ID), and/or developmental delay (DD). 
Methods: Data were obtained from the Centers for Disease Control and Prevention’s nation-
ally representative Survey of Pathways to Diagnosis and Services. Respondents were classified 
according to whether their child had ASD without ID or DD (ASD-only), ASD with ID and/or 
DD (ASD+ID/DD), or ID and/or DD without ASD (ID/DD-only). Respondents rated the extent 
to which they believed that genetics/heredity and environmental exposures (prenatal and/or 
postnatal) had contributed to their child’s condition. Logistic regression analyses and chi-square 
tests were used to assess the relationship between parental beliefs and child characteristics. 
Results: The parents of children with comorbid ASD and ID/DD were found to be significantly 
less likely than those in the other condition groups to attribute their child’s condition to genetics. 
Within the ASD+ID/DD group, parental endorsement of genetics was lower among those who 
reported a history of language regression (p=0.006).
Conclusion: Further research is needed to evaluate the impact of parental genetic attributions 
on medical decision-making.
Keywords: parental beliefs, etiology, developmental disabilities, autism spectrum disorders, 
intellectual disability
Introduction
The rising prevalence of autism spectrum disorders (ASD) in the USA has fueled 
scientific and popular interest in the causes of this condition.1 As a growing body of 
research continues to reveal the genetic heterogeneity underlying the autism spectrum, 
clinical genetics professionals are likely to play an increasingly important role in the 
medical assessment of affected children.2,3 In recognition of the potential benefits of 
obtaining a genetic diagnosis, the American College of Medical Genetics and Genomics 
has recommended that genetic testing be offered to all children with ASD.4 However, 
genetics services remain underutilized in this population, and recent studies suggest 
that less than half of all children with ASD undergo recommended genetic testing.5,6 
Barriers to the utilization of genetics services in this population include limited parental 
awareness of genetic testing options, concerns about cost, and uncertainty about the 
value of a genetic diagnosis.6,7
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Although clinicians play a vital role in facilitating access 
to genetics services for children with ASD, decisions about 
whether to pursue genetic testing ultimately rest with the par-
ents themselves, who may act on physician recommendations 
and interpret the results of genetic testing in the context of 
their existing beliefs about ASD etiology.7,8 Studies of paren-
tal etiological attributions have produced varying estimates 
of the proportion of parents that believe their child’s ASD has 
a genetic basis; a 2006 survey of 41 parents found that more 
than 90% believed that genetic influences had contributed to 
their child’s ASD, while another study from the same year 
reported that just 26% of their 62-parent sample endorsed 
genetic predisposition as a cause.9,10 These studies have also 
documented the wide range of nongenetic causes to which 
parents commonly attribute their child’s ASD, including 
prenatal exposures, perinatal events, vaccinations, dietary 
sensitivities, child illnesses, parental age, environmental 
toxins, and other factors.9–13
In addition to influencing their utilization of genetics ser-
vices, parental etiological attributions may shape a range of 
other medical decisions. A survey-based study of more than 
250 parents of children with ASD concluded that parental 
perceptions of recurrence risk frequently affected family 
planning decisions, especially among those who perceived 
their recurrence risk to be high.11 Likewise, population-based 
studies have found evidence that families commonly engage 
in “reproductive stoppage” after a child is diagnosed with 
ASD.14 Etiological attributions to nongenetic factors may 
also influence treatment decisions; concerns about a causal 
relationship between vaccines and ASD have commonly 
been given as a reason for vaccine refusal, which has been 
linked to recent measles outbreaks in the USA.15–17 Parental 
endorsement of food allergies as a cause of ASD has also 
been associated with use of chelation, a controversial inter-
vention that lacks demonstrated efficacy and carries a risk 
of death.12,18
Collectively, these findings highlight the clinical rel-
evance of parental etiological attributions and underscore 
the need for research aimed at understanding the factors that 
influence these beliefs. Studies of cross-cultural variation in 
ASD perceptions have identified numerous factors – includ-
ing social norms and religious or spiritual beliefs – that may 
contribute to cultural differences in parental appraisal of ASD 
symptoms.19,20 In addition, parental etiological beliefs about 
ASD have been shown to differ according to ethnicity, family 
structure, and income in the USA.21 However, it is not known 
to what extent differences in child clinical presentation may 
contribute to variation in parental beliefs about ASD etiology. 
The autism spectrum is highly heterogeneous with respect 
to symptom severity and cognitive functioning, encompass-
ing nonverbal children with severe intellectual impairments 
along with those who test in the superior range on measures 
of cognitive ability. Several lines of evidence suggest that, 
compared to children with either condition alone, children 
with ASD and co-occurring cognitive impairment present 
with a distinct clinical profile that includes an earlier age 
of parent-reported onset and an increased risk for comorbid 
psychopathology and challenging behaviors.22–24 Given the 
potential for parental etiological attributions to be influenced 
by these factors, the aim of the present study was to compare 
the causal beliefs held by the parents of children with ASD 
and comorbid intellectual disability (ID) and/or develop-
mental delay (DD) to those held by the parents of children 
with either ASD or ID/DD alone. A better understanding 
of the determinants of parental beliefs about ASD etiology 
may facilitate improved communication between genetics 
professionals and affected families.
Methods
Data were analyzed from the 2011 Survey of Pathways to 
Diagnosis and Services (“Pathways”). The Pathways sur-
vey was conducted by the Centers for Disease Control and 
Prevention (CDC) through the National Center for Health 
Statistics, State and Local Area Integrated Telephone Survey 
program. This survey was a follow-up to the 2009–2010 
National Survey of Children with Special Health Care Needs 
(NS-CSHCN), a cross-sectional, random-digit-dial telephone 
survey of the parents and guardians of US children with spe-
cial health care needs (CSHCN) between the ages of 0 and 17. 
A random sample of 6,090 NS-CSHCN respondents who had 
previously indicated that their child had ever been diagnosed 
with ASD, ID, and/or DD were selected to be recontacted for 
the Pathways survey. Those who were successfully contacted 
were further screened to confirm that the eligible child was 
between the ages of 6 and 17 at the time of the interview, 
continued to live with the respondent, and had been diagnosed 
with one of the abovementioned developmental conditions. 
The Pathways interview was completed by 4,032 respondents. 
Weighted estimates derived from the Pathways dataset are 
representative of the US population of noninstitutionalized 
CSHCN who have ever been diagnosed with ASD, ID, and/or 
DD. As a secondary analysis of publicly available, deidenti-
fied data, this study was exempt from Institutional Review 
Board approval.
The present analysis was limited to respondents who 
indicated that their child had ASD, ID, and/or DD at the 
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time of the Pathways interview, based on three questions 
about whether, to the best of the respondent’s knowledge, the 
child currently had “autism or an autism spectrum disorder,” 
“an intellectual disability or mental retardation,” and/or 
“a developmental delay that affected his/her ability to learn.” 
Respondents who met these criteria were further classified 
into three condition groups: 1) those whose children currently 
had ASD, without ID or DD (“ASD-only” n=492); 2) ASD 
with ID and/or DD (“ASD+ID/DD” n=913); or 3) ID and/
or DD, without ASD (“ID/DD-only” n=1,949). Pathways 
respondents who had previously indicated that their child 
had Down syndrome were excluded.
Parental beliefs about the etiology of their child’s devel-
opmental disabilities were assessed based on three questions. 
Respondents were asked whether they thought that their 
child’s condition was 1) “genetic or hereditary”; 2) “caused 
by something he/she was exposed to in utero, that is, before 
he/she was born”; and 3) “caused by something he/she was 
exposed to after he/she was born.” These questions were 
adapted from the Revised Illness-Perception Questionnaire 
modified for autism (IPQ-RA). A scale was used for each 
question, with possible responses of “definitely agree,” 
“somewhat agree,” “somewhat disagree,” and “definitely 
disagree.” Respondents were also permitted to answer “don’t 
know” to each question. In the present analysis, responses 
were dichotomized into those who endorsed (answered 
“definitely agree” or “somewhat agree”) or did not endorse 
(answered “definitely disagree,” “somewhat disagree,” or 
“don’t know”) each of the three causes.
The proportion of respondents that endorsed each of the 
three etiologic categories (genetics, prenatal environmental 
exposures, and postnatal environmental exposures) was cal-
culated separately for the ASD-only, ASD+ID/DD, and ID/
DD-only groups. Multivariable logistic regression analyses 
were used to compare beliefs between groups. Age, sex, race, 
ethnicity, household income, and household education level 
were included in the models to control for the potentially 
confounding effects of these demographic characteristics.
Respondents were further classified based on the com-
bination of responses they provided to the three etiology 
questions: 1) those who endorsed genetics but did not endorse 
prenatal or postnatal exposures (hereafter referred to as 
“predominantly genetic”); 2) those who endorsed prenatal 
and/or postnatal exposures but did not endorse genetics 
(“predominantly environmental”); 3) those who endorsed 
genetics plus prenatal and/or postnatal exposures (“genetic 
and environmental”); and 4) those who endorsed neither 
genetics nor environmental exposures (“neither”). Multivari-
able logistic regression analyses were used to compare the 
prevalence of each of these response patterns across the three 
groups (ASD-only, ASD+ID/DD, and ID/DD-only). All mod-
els controlled for demographic characteristics (age, sex, race, 
ethnicity, household income, household education level).
Further analyses were performed to assess the association 
between parental beliefs and the child’s developmental char-
acteristics. Information about the child’s history of regression 
was obtained through a question about whether, at the time 
that the parent’s concerns began, they felt that some of the 
child’s “speech skills that he/she had already developed were 
lost.” This question was only asked of parents who reported 
that the child’s age at the onset of their concerns was at least 9 
months. Rao–Scott χ2 tests were used to compare the propor-
tion of respondents that endorsed each of the three etiologic 
categories (between those who did and did not report a history 
of language regression).
Results
Across all groups, a majority of respondents – including 72% 
of the ASD-only group, 57% of the ASD+ID/DD group, and 
67% of the ID/DD-only group – identified genetic or hereditary 
factors as a cause of their child’s condition (Table 1). By con-
trast, a minority of respondents in each group endorsed prenatal 
(28%–33%) or postnatal (25%–40%; Table 1) environmental 
exposures. Logistic regression analyses showed that, after 
adjusting for demographic factors, respondents in the ASD+ID/
DD group were significantly less likely than those in the ASD-
only and ID/DD-only groups to attribute their child’s condition 
to genetics/heredity (adjusted odds ratio [aOR] =0.6 for both; 
Table 2). Although endorsement of postnatal exposures did 
not differ between the two ASD groups, respondents in both 
were significantly more likely than those in the ID/DD-only 
group to attribute their child’s condition to exposures after 
birth; just 25% of the  ID/ DD-only group (Table 1) endorsed 
postnatal exposures, compared to 34% of the ASD-only group 
(aOR =1.7; Table 2) and 40% of the ASD+ID/DD group (aOR 
=2.0). Parental endorsement of prenatal exposures did not dif-
fer between condition groups (Table 2).
Similar patterns emerged when respondents were clas-
sified according to the combination of responses that they 
provided to the three etiologic questions in the Pathways 
survey. Although a significant proportion of respondents in 
each group attributed their child’s condition to both genetic 
factors and environmental exposures (29%–32%; Table 1), 
many appeared to favor one over the other, endorsing 
either genetics/heredity but not environmental exposures 
(“predominantly genetic”), or exposures but not genetics/
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heredity (“predominantly environmental”). However, the 
distribution of respondents between the “predominantly 
genetic” and “predominantly environmental” response 
categories differed among the three condition groups. In 
the ASD-only and ID/DD-only groups, the “predominantly 
genetic” response pattern was more common (ASD-only: 
41%; ID/DD-only: 37%; Table 1) than the “predominantly 
environmental” one (ASD-only: 15%; ID/DD-only: 16%). In 
the ASD+ID/DD group, by contrast, respondents were more 
evenly split, with roughly equal percentages of respondents 
falling into the “predominantly genetic” and “predominantly 
environmental” categories (25% each; Table 1). Multivari-
able logistic regression analyses showed that, compared to 
those in either of the other condition groups, respondents in 
the ASD+ID/DD group were significantly less likely to hold 
“predominantly genetic” beliefs (ASD-only: aOR=0.5; ID/
DD-only: aOR=0.5; Table 2) and significantly more likely 
to hold “predominantly environmental” beliefs (ASD-only: 
aOR=1.8; ID/DD-only: aOR=1.7).
Within each group, Rao–Scott χ2 tests were performed 
to examine the relationship between parental beliefs and 
parent report of language regression. In the ASD-only and 
ID/DD-only groups, no associations were identified between 
regression history and parental beliefs (Table 3). However, in 
the ASD+ID/DD group, respondents who reported that their 
child had a history of regression were significantly less likely 
to endorse genetics (p=0.006) and significantly more likely 
to endorse postnatal exposures (p<0.001) as contributors to 
their child’s developmental disabilities, compared to those 
who reported no history of regression (Table 3).
Discussion
Numerous studies have documented the wide range of genetic 
and nongenetic factors to which parents commonly attribute 
their child’s ASD. Although the diversity in these etiological 
explanations rivals the heterogeneity of the autism spectrum 
itself, little is known about the factors that influence these 
beliefs, and it is unclear whether parental etiological attri-
Table 1 Prevalence of etiological attributions by condition group
Condition  
group
Genetic Environmental Both  
genetic and 
environmental  
(%)
Neither  
(%)Any genetic  
(%)
Predominantly 
genetic  
(%)
Any prenatal 
exposure  
(%)
Any postnatal 
exposure  
(%)
Predominantly 
environmental  
(%)
ASD+ID/DD 56.8±2.9 25.3±2.4 33.0±2.7 39.8±2.9 25.4±2.5 31.5±2.8 17.6±2.2
ASD-only 71.8±3.7 40.7±4.1 28.1±3.9 33.9±3.9 15.4±3.1 31.0±3.7 12.8±2.6
ID/DD-only 66.5±2.1 37.4±2.2 31.6±2.0 24.6±2.1 15.8±1.4 28.7±2.2 17.6±1.9
Notes: Respondents were asked to indicate the extent to which they believed that genetics/heredity, prenatal exposures, and postnatal exposures had contributed to 
their child’s condition. The “Any genetic” column shows the proportion of respondents that endorsed (answered “definitely” or “somewhat” agree) genetics/heredity; 
“Predominantly genetic” column shows the proportion that endorsed genetics but not environmental exposures; “Any prenatal” and “Any postnatal” columns show 
the proportion that endorsed prenatal exposures and postnatal exposures, respectively; “Predominantly environmental” column shows the proportion that endorsed 
environmental exposures but not genetics; “Both” column shows the proportion that endorsed genetics and environmental exposures; “Neither” column shows the 
proportion that did not endorse any of the three causes.
Abbreviations: ASD, autism spectrum disorders; DD, developmental delay; ID, intellectual disability.
Table 2 Comparison of etiological attributions by condition group
Condition 
group
Genetic Environmental Both
genetic and 
environmental
aOR (95% CI)
Neither
Any genetic
aOR (95% CI)
Predominantly 
genetic
aOR (95% CI)
Any prenatal 
exposure
aOR (95% CI)
Any postnatal 
exposure
aOR (95% CI)
Predominantly 
environmental
aOR (95% CI)
ASD+ID/DD vs 
ASD-only
0.6 (0.4–0.9)* 0.5 (0.3–0.8)* 1.3 (0.8–2.0) 1.2 (0.8–1.9) 1.8 (1.0–3.1)* 1.1 (0.7–1.7) 1.4 (0.8–2.5)
ASD+ID/DD vs 
ID/DD-only
0.6 (0.5–0.9)* 0.5 (0.4–0.7)* 1.1 (0.8–1.5) 2.0 (1.4–3.0)* 1.7 (1.2–2.5)* 1.2 (0.8–1.8) 1.1 (0.7–1.7)
ASD-only 
vs 
ID/DD-only 
1.2 (0.8–1.8) 1.0 (0.7–1.5) 0.9 (0.5–1.3) 1.7 (1.1–2.6)* 1.0 (0.6–1.7) 1.1 (0.7–1.7) 0.8 (0.5–1.4)
Notes: Respondents were asked to indicate the extent to which they believed that genetics/heredity, prenatal exposures, and postnatal exposures had contributed to their 
child’s condition. Parental endorsement of genetics/heredity, prenatal exposures, and postnatal exposures were compared across groups. Multivariable logistic regression 
analyses controlled for age, sex, race, ethnicity, household income level, and household education level. *Significance, set at the p<0.05 level.
Abbreviations: aOR, adjusted odds ratio; ASD, autism spectrum disorders; CI, confidence interval; DD, developmental delay; ID, intellectual disability.
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butions differ according to the child’s cognitive status. The 
aim of the present study was to use data from a nationally 
representative sample of more than 3,000 respondents to 
compare the etiologic beliefs held by the parents of children 
with ASD and comorbid ID and/or DD (ASD+ID/DD) to 
those held by the parents of children with either condition 
alone (ASD-only or ID/DD-only).
A majority of respondents in the Pathways sample 
believed that their child’s condition had a genetic or heredi-
tary basis. Among the parents of children with ASD, the 
proportion of respondents that endorsed genetics/heredity 
was 57% for the ASD+ID/DD group and 72% for the ASD-
only group. Additionally, more than one-fourth (29%–32%) 
of each condition group attributed their child’s condition to 
both genetics and environmental (prenatal and/or postnatal) 
exposures. These estimates are reasonably consistent with 
the findings of a 2009 study that reported that 73% of their 
sample attributed their child’s ASD to genetic influences.11 
However, the results of the present analysis diverge from 
the findings of a number of other studies, including one that 
reported that just 26% of respondents believed that their 
child’s ASD had a genetic basis.10 These discrepancies may 
be due in part to differences in respondent characteristics; 
whereas the prior studies utilized relatively small convenience 
samples, the Pathways study was designed to be nationally 
representative.
When the three condition groups were compared, the 
parents of children with ASD and comorbid intellectual/DDs 
showed a greater tendency to attribute their child’s condition 
to nongenetic factors than the parents of children with either 
condition alone. After controlling for demographic factors, 
parents in the ASD+ID/DD group were significantly less 
likely to attribute their child’s condition to genetics/heredity 
than those in either the ASD-only or ID/DD-only groups. 
Moreover, when respondents were classified according to the 
combination of responses they provided to the three etiology 
questions in the Pathways survey, those in the ASD+ID/DD 
group were significantly more likely to hold “predominantly 
environmental” beliefs, and less likely to hold “predomi-
nantly genetic” beliefs, than their counterparts in the other 
condition groups.
Additional analyses identified a subset of respondents in 
the ASD+ID/DD group that were especially likely to sub-
scribe to nongenetic, external explanations for their child’s 
disabilities. Among the parents of children with ASD+ID/DD, 
those who reported that their child had a history of language 
regression were significantly more likely to endorse postnatal 
exposures as a contributor to their child’s condition, and less 
likely to endorse genetics, than those who indicated that their 
child had not regressed. These findings are consistent with 
the results of a 2005 survey that compared etiologic beliefs 
between parents who reported that their child had always 
had symptoms of ASD (“congenital”) and those who indi-
cated that their child had regressed after a period of normal 
development (“ regressive”).25 In that study, parents in the 
“congenital” group were more likely to view their child’s 
condition as genetic, whereas those in the “regressive” group 
were more likely to attribute their child’s ASD to external fac-
tors. Although the Pathways survey did not directly assess the 
extent to which beliefs influenced parental decision-making 
in this sample, a number of controversial practices for pre-
venting or treating ASD – such as chelation, withholding of 
immunizations, antibiotics, antiviral agents, and high-dose 
vitamins – are predicated on the belief that external factors 
can trigger or worsen the symptoms of ASD. Thus, future 
studies should aim to characterize the relationship between 
parental etiological attributions and use of these alternative 
therapies.
Although the use of the large, nationally representative 
Pathways sample was a major strength of the present analysis, 
the survey-based design of this study was also associated 
with a few limitations. The Pathways interview asked parents 
to rate the extent to which they believed that three broad 
categories of etiologic factors (genetics/heredity, prenatal 
Table 3 Association between history of language regression and parental beliefs
Condition  
group
Genetic Prenatal Postnatal
Reg. (%) Non-reg. (%) p-value Reg. (%) Non-reg. (%) p-value Reg. (%) Non-reg. (%) p-value
ASD-only 63.2±9.0 72.9±4.5 0.317 34.1±9.1 17.4±3.9 0.065 45.5±10.1 26.4±4.2 0.070
ASD+ID/DD 48.2±5.0 66.6±4.1 0.006* 32.3±4.8 31.6±4.0 0.907 51.2±5.0 28.9±3.8 <0.001*
ID/DD-only 71.8±4.0 69.5±3.0 0.649 31.8±4.2 31.1±2.8 0.897 23.8±3.6 22.8±2.5 0.816
Notes: Within each condition group, χ2 tests were used to compare rates of endorsement of each etiologic category (genetics, prenatal exposures, postnatal exposures) 
between respondents who reported that their child had a history of language regression and those who reported no regression. *Significance, set at the p<0.05 level.
Abbreviations: ASD, autism spectrum disorders; DD, developmental delay; ID, intellectual disability; reg, regression; non-reg, no regression.
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exposures, and postnatal exposures) had contributed to their 
child’s condition. A drawback of this format is that it did not 
permit assessment of the prevalence of specific etiologic 
attributions. Parents who endorsed postnatal exposures, for 
example, may have attributed their child’s condition to factors 
as diverse as vaccines, heavy metals, infections, medications, 
or other substances. The format of this survey also precluded 
assessment of etiologic beliefs that did not fall into any of 
the three categories encompassed by the Pathways questions. 
Notably, 13%–18% of each group analyzed in this study did 
not endorse any of the three etiologic categories. Previous 
studies based on open-ended questions have identified a num-
ber of parental etiologic attributions that were not addressed 
in the Pathways survey, including religious or superstitious 
factors, parental age, and other causes.20
Another limitation of the present study is that the Path-
ways survey relied on parent-reported diagnoses that were 
not independently verified. Recent records-based epidemio-
logical studies conducted by the CDC have estimated that 
31%–41% of children with ASD have an IQ consistent with 
ID (≤70), with an additional 21%–24% falling in the “Bor-
derline” (71–85) range.26–28 By contrast, just 21% of children 
with ASD in the Pathways sample were reported to have ID, 
while 44% were reported to have ASD+DD without ID. This 
suggests that ID may have been underreported in this sample, 
and that some of the children who were identified as having 
ASD+DD may have had cognitive impairment consistent 
with ID even if the parents reported otherwise. Thus, the 
present study grouped children with ASD-only separately 
from those with ASD plus ID and/or DD (ASD+ID/DD) to 
preserve the distinction between children with normal intel-
lectual functioning and those with some degree of cognitive 
impairment. This  classification is supported by the fact 
that, among children with ASD in the Pathways sample, the 
prevalence of comorbid ID and/or DD (65%) roughly cor-
responds to the total percent of children in the records-based 
epidemiological studies (54%–62%) that tested below the 
average range on measures of IQ (≤85).26–28 However, the 
ASD+ID/DD group was likely clinically heterogeneous, and 
the inability to corroborate parent-reported diagnoses with 
validated measures of functioning represents a significant 
limitation of the present study.
Conclusion
Notwithstanding the limitations discussed above, the find-
ings of this study are highly relevant to clinicians who 
provide care to children with developmental disabilities 
and their families. Genetics professionals, in combination 
with other clinicians involved in the diagnostic process 
– including psychiatrists, developmental pediatricians, 
neurologists, and primary care providers – play a vital role 
in educating parents about etiology and helping them to 
access recommended genetics services for their children. 
This study showed that the parents of children with ASD 
and comorbid ID/DD were significantly less likely than the 
parents of children with either condition alone to attribute 
their child’s condition to genetic or  hereditary factors, 
especially if the child had a history of language regression. 
Given that parental etiological attributions may influence 
their utilization of numerous services for their children, 
including genetic testing, an awareness of the factors that 
influence parental etiological beliefs may allow clinicians 
to provide more individualized counseling to affected 
families. Overall, it is hoped that a better understanding of 
the determinants and consequences of parental etiological 
beliefs will facilitate improved access to genetics services 
in this population.
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